Search Results for keywords:"Ulta Salon Cosmetics

The U.S. International Trade Commission has decided not to review a ruling by the administrative law judge allowing changes to a complaint in an investigation concerning artificial eyelash extension systems. The original complaint by Lashify, Inc. claimed that certain products were imported or sold in the U.S., infringing on some of their patents. The investigation originally named CVS Health Corporation and Ulta Beauty, Inc. as respondents, but the ruling allows substituting them with CVS Pharmacy, Inc. and Ulta Salon, Cosmetics & Fragrance, Inc. This decision means the investigation will proceed with these updated parties, and authority for this determination comes from the Tariff Act of 1930.

AI Infrastructure Alliance, Inc. (AIIA) has informed the Attorney General and the Federal Trade Commission about changes in its membership as of December 6, 2024, in compliance with the National Cooperative Research and Production Act of 1993. This notice lists multiple organizations that have withdrawn from the group, including companies from countries like Germany, Israel, and Ireland. The Department of Justice had previously published notice of AIIA's original notification and its last update. No alterations have been made to the group's planned activities.

The Food and Drug Administration (FDA) is proposing a rule to require testing of talc-containing cosmetic products to detect and identify asbestos, which is a known carcinogen. This rule would mandate the use of standardized testing methods involving both Polarized Light Microscopy and Transmission Electron Microscopy to ensure that cosmetics do not contain asbestos, which poses health risks to consumers. Manufacturers would need to test each batch or lot of their products or rely on certified analysis from suppliers, and they must maintain records of the testing. This rule aims to enhance consumer safety by reducing the risk of asbestos exposure from cosmetic products.

The Food and Drug Administration (FDA) is inviting public feedback on its proposed collection of information related to adverse events and product experiences for FDA-regulated products. As part of fulfilling requirements under the Paperwork Reduction Act, the FDA seeks comments on whether this information collection is necessary, its accuracy, and ways to minimize the burden on respondents. They have updated forms and processes to standardize data collection, improve quality and clarity, and ensure confidentiality where necessary. The deadline for providing comments, either electronically or by mail, is March 18, 2025.

The U.S. International Trade Commission (ITC) is requesting written submissions from parties involved in a case concerning certain eye cosmetics and their packaging. This case involves allegations of unfair practices like trademark infringement and false advertising. Various companies, mostly based abroad, are named as respondents. The ITC is considering potential remedies, including exclusion orders to prevent the entry of these products into the U.S., and is particularly interested in how such actions could impact public interests like health, competition, and consumer choices. The Commission is also inviting comments on bond amounts if a remedy is enforced, and decisions on the case are ongoing.

The Food and Drug Administration (FDA) has decided to revoke the use of the color additive FD&C Red No. 3 in foods and ingested drugs. This decision was based on evidence showing that FD&C Red No. 3 can cause cancer in male rats, which under the law, makes it unsafe. Although the risk to humans is considered low, the FDA is compelled by law to remove this additive because it has been linked to cancer in animals. The order will take effect on January 15, 2027, but objections can be submitted until February 18, 2025, if anyone is adversely affected by this ruling.

The Department of Agriculture is seeking feedback on an information collection request as part of its regulatory duties under the Coordinated Framework for the Regulation of Biotechnology. This effort involves a web-based platform established in partnership with the Environmental Protection Agency and the Food and Drug Administration to facilitate queries and provide guidance on biotechnology products. Public comments on the necessity, practicality, and burden of this information collection, which gathers minimal personal contact information through a voluntary web form, are invited until January 2, 2025. The goal is to ensure that federal biotechnology regulations are both effective and accessible to innovators.

The National Agricultural Statistics Service (NASS) is seeking approval to conduct a new information collection to gather data on hemp production. This initiative is in accordance with the Paperwork Reduction Act of 1995 and will help inform programs under the 2018 Farm Bill. The survey will target up to 20,000 farmers and ranchers, with an estimated burden of 15 minutes per response. Public comments on this proposed data collection must be submitted by April 26, 2021, to ensure consideration.

The Food and Drug Administration (FDA) has released a final guidance for the cosmetic industry titled “Registration and Listing of Cosmetic Product Facilities and Products.” This guidance aims to help companies with the registration and listing process required by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). It includes a draft section in Appendix B with new questions and answers, open for public comment. The guidance underscores that small businesses are exempt from these regulations and invites comments to be submitted by January 13, 2025.

The Environmental Protection Agency (EPA) has released draft national recommended water quality criteria for public comment, focusing on three per- and polyfluoroalkyl substances (PFAS): perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorobutane sulfonic acid (PFBS). These criteria are designed to protect human health and are based on the latest scientific data, providing states and tribes with information for setting their own water quality standards. Comments on this draft can be submitted until February 24, 2025, and the EPA will use this feedback to finalize the criteria. Once finalized, these recommendations will offer guidance on minimizing health risks from PFAS exposure in drinking water and aquatic food sources.